Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The goal of the CRIS-PM Drug Development Fellowship is to train early career investigators from Spain, France and UK (and potentially other countries) at the PM-UHN in Toronto, Canada, in experimental therapeutics and translational research.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Research grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: mlopez4@researchmar.net Ext.: 1576
Mercedes Bayo: mbayo@researchmar.net Ext.: 1684
Convocatòria (URL)
https://criscancer.org/es/cris-princess-margaret-cancer-centre/
https://criscancer.org/wp-content/uploads/2024/03/TC-CRIS-PMCC-DDFP-2024.pdf
Requisits
  • Board Certified Medical Oncologist or MD who completed the Internal Medicine Residency Program and is board eligible
  • Spain, France or UK nationality (other countries may be considered)
  • English proficiency in reading and writing
    • Dotació
    CAD $95,000 (plus 11% benefits) for a gross salary of CAD $105,450
    Durada
    2 years
    Documentació
    Each Candidate must provide the following:
  • Curriculum Vitae (maximum 4 page)
  • Motivation Statement (maximum 500 words)
    - Brief Summary of your training and academic interest
    - What drives you to purse the CRIS-PM Drug Development Fellowship Program?
    - How would attending the CRIS-PM Drug Development Fellowship Program impact your career?
    		•

    Arxius

    Arxiu
    TC-CRIS-Princess Margaret Cancer Center-DDFP-2024.pdf